Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey 

Slides:



Advertisements
Similar presentations
Pinja Ilmarinen, PhD, Leena E
Advertisements

Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities  Dr Mateusz M Plucinski,
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive.
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?  Dr Simone Lanini, MD, Prof Alimuddin.
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility  Simon Cauchemez,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China  Z. Gong, S. Gu, Y. Zhang, J. Sun, X. Wu, F.
Rapid antigen testing for the surveillance of influenza epidemics
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
Human asymptomatic Ebola infection and strong inflammatory response
Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis 
Transmission of Staphylococcus aureus between health-care workers, the environment, and patients in an intensive care unit: a longitudinal cohort study.
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Approach to diagnosis of infective endocarditis
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study  Dr Timothy M Walker, MRCP, Camilla LC.
Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study  Dr Edward Green, MRCP, Luke Hunt,
John N Nkengasong, Philip Onyebujoh  The Lancet 
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities  Dr Mateusz M Plucinski,
Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013  Ann-Beth Moller, MPH, Max Petzold,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Ecology of zoonoses: natural and unnatural histories
Ebola superspreading The Lancet Infectious Diseases
Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study  Matthew Waxman, MD,
What Clinicians Should Know About the 2014 Ebola Outbreak
Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China  Z. Gong, S. Gu, Y. Zhang, J. Sun, X. Wu, F.
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study  Daouda.
J. Zhang, X. -F. Zhang, C. Zhou, Z. -Z. Wang, S. -J. Huang, X. Yao, Z
Future challenges for clinical care of an ageing population infected with HIV: a modelling study  Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report  Emily Kainne Dokubo, MD, Annika Wendland, MPH, Suzanne.
Brian J Coburn, Sally Blower  The Lancet Infectious Diseases 
Prevalence of mycoplasma encephalitis
Low risk of a sexually-transmitted Zika virus outbreak
Frequency and implications of HIV superinfection
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?  Dr Simone Lanini, MD, Prof Alimuddin.
Hepatitis C Virus Infection in the Older Patient
Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study  Ousmane Faye, PhD, Pierre-Yves Boëlle,
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive.
Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia  V. Peltola, M. Waris, L. Kainulainen, J.
Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing  Dr.
Human asymptomatic Ebola infection and strong inflammatory response
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational.
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health- care capacity, and the potential effect of mitigation strategies:
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety.
Ecology of zoonoses: natural and unnatural histories
Priya Sampathkumar, MD, Zelalem Temesgen, MD, Thomas F
Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic.
C.G. Teo  Clinical Microbiology and Infection 
Cases of travel-acquired dengue fever in Denmark 2001–2009
C.B. Reusken, M. Ieven, L. Sigfrid, I. Eckerle, M. Koopmans 
Effect of antioxidants on the immune response of Helicobacter pylori
Excretion of infectious Zika virus in urine
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study  Dilrini De Silva, PhD, Joanna Peters, MBBS, Kevin.
Pinja Ilmarinen, PhD, Leena E
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility  Simon Cauchemez,
Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis  Joseph A Lewnard, BA, Martial L Ndeffo Mbah,
Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona  S. Borrell, G. Tudó, E. Rey, J. González-Martín 
Long-term circulation of Zika virus in Thailand: an observational study  Kriangsak Ruchusatsawat, PhD, Pattara Wongjaroen, MSc, Arisara Posanacharoen,
From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging Pathogens
Volume 392, Issue 10160, Pages (November 2018)
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation 
Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers  Dr Michael Jacobs, FRCP,
Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand’s disease in a family cluster  Pramod S. Kelkar, MD, Rosa M. Ten,
Alcoholic Cardiomyopathy and Ventricular Arrhythmias
Clinical Microbiology and Infection
Presentation transcript:

Early transmission and case fatality of Ebola virus at the index site of the 2013–16 west African Ebola outbreak: a cross-sectional seroprevalence survey  Joseph W S Timothy, PhD, Yper Hall, PhD, Joseph Akoi-Boré, MSc, Boubacar Diallo, MD, Thomas R W Tipton, PhD, Hilary Bower, MSc, Thomas Strecker, PhD, Judith R Glynn, PhD, Miles W Carroll, PhD  The Lancet Infectious Diseases  Volume 19, Issue 4, Pages 429-438 (April 2019) DOI: 10.1016/S1473-3099(18)30791-6 Copyright © 2019 World Health Organization Terms and Conditions

Figure 1 Mean NOD values from oral fluid samples of all study participants using anti-Ebola virus IgG capture assay Samples are ranked by mean NOD value (except the positive controls). All samples were run in duplicate. (A) Mean NOD values of all samples. (B) Mean NOD values of samples with NOD >0·8, for improved resolution. The majority of a priori suspected cases clustered around the highest ranked NOD values. The dashed lines show NOD values of 1·1 and 0·9. NOD values >1·1 were classified as seropositive. NOD=normalised optimal density. The Lancet Infectious Diseases 2019 19, 429-438DOI: (10.1016/S1473-3099(18)30791-6) Copyright © 2019 World Health Organization Terms and Conditions

Figure 2 Probable Ebola virus transmission chain based on clinical symptoms of infection and anti-Ebola virus IgG serological results The transmission chain includes all clinically suspected cases for which symptoms were confirmed by key informants (even if seronegative or if serology was not done), all seropositive survivors, and all suspected EVD deaths. The most likely routes of infection are shown, based on the highest level of exposure to a patient with EVD reported during group interviews. Dashed arrows show multiple plausible routes of infection. Red boxes show EVD death. Green boxes show seropositive EVD survivors. White boxes show clinically suspected cases of EVD in patients who were IgG seronegative (S14, S16, and S20) or were too young to collect oral fluid samples (S15). Solid parentheses show multiple potential cases arising from a single source (amplification event). Dashed parentheses towards S18 show uncertainty of the main route of transmission due to extensive level 1–2 exposures to patients S1–S17. HH indicates the individual's household of residence at the onset of symptoms. Relationships described in parentheses within each box describe the relationship of that individual to the probable source of their infection (upstream origin of arrow). HHC and HHC2 denote different dwellings in the same household. Households denoted as HHNA were not given household suffixes because HH was assigned on the basis of the first appearance of symptoms and neither case developed symptoms in Meliandou. EVD=Ebola virus disease. HCW=health-care worker. The Lancet Infectious Diseases 2019 19, 429-438DOI: (10.1016/S1473-3099(18)30791-6) Copyright © 2019 World Health Organization Terms and Conditions